Pfizer (PFE) reported Q1 FY2025 earnings of $0.92 per share (versus $0.82 per share in Q1 FY2024), beating analysts’ consensus estimate of $0.67 per share.
The company’s quarterly revenues amounted to $13.715 bln (-7.8% y/y), missing analysts’ consensus estimate of $13.920 bln.
The company also issued in-line guidance for FY2025, seeing EPS of $2.80-3.00 versus analysts’ consensus estimate of $2.94 and revenues of $61.0-64.0 bln versus analysts’ consensus estimate of $62.8 bln.
PFE rose to $23.20 (+0.65%) in pre-market trading.
